¼Ò¾Æ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ ÈÇпä¹ý¿¡ µû¸¥ È£Áß±¸ °¨¼Ò¿¡ ´ëÇÑ Filgrastim(rhG-CSF)ÀÇ È¿°ú
Effect of Filgrastim(rhG-CSF) on Chemotherapy Induced Neutropenia in Pediatric Acute Myelogenous Leukemia Patients
´ëÇѾÏÇÐȸÁö 1994³â 26±Ç 1È£ p.136 ~ p.143
½ÅÈñ¿µ(Shin Hee-Young) - ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¹Ú°æ´ö(Park Kyung-Duk) - ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÇϼºÈÆ(Ha Seong-Hoon) - ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±¸È«È¸(Koo Hong-Hoe) - ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¾ÈÈ¿¼·(Ahn Hyo-Seop) - ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Abstract
To determine the safety and efficacy of rhG-CSF on chemotherapy induced neutropenia in pediatric AML patients, we conducted a prospective controlled study in 17 patiens with AML at Seoul National University Childrens Hospital from July, 1993 to January, 1994. High dose cytosine arabinoside(Ara-C, 3gm/m for four times every 12 hours) with L-asparaginase 6,000 u/m) were given to 13 patients as Group I control and after the recovery of WBC, same chemo- therapy followed by G-CSF(50 ug/m for 10 days) were given as Group I study. In Group II study, high dose Ara-C(3gm/m(2) for 8 times every 12 hours) were given to 11 patients with AML followed by G-CSF(150 ug/m for 10 days). Recovery of the absolute neutrophil counts to more than 1,000/mm¡¯ was significantly faster in the G-CSF group than in the control group(P< 0.01) and the absolute neutrophil counts on day 14 of chemotherapy was significantly higher in G-CSF group(P<0.01). The toxicity of G-CSF was minimal and there was no evidence of accel- erated growth of leukemic blasts during the G-CSF treatment. In conclusion, Filgrastim(rhG- CSF) promotes the recovery of neutrophils and shortens the duration of neutropenia induced by the chemotherapy in pediatric acute myelogenous leukemia.
Key words: Filgrastim, G-CSF
Å°¿öµå
Filgrastim, G-CSF, Childhood, AML, Neutropenia, Chemotherapy
KMID :
0360319940260010136
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Filgrastim(rhGCSF) promotes the recovery of neutrophils and shortens the duration of neutropenia induced by the chemotherapy in pediatric acute myelogenous leukemia.